Page last updated: 2024-11-07

prednisone and Erdheim-Chester Disease

prednisone has been researched along with Erdheim-Chester Disease in 12 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Erdheim-Chester Disease: A rare form of non-Langerhans-cell histiocytosis (HISTIOCYTOSIS, NON-LANGERHANS-CELL) with onset in middle age. The systemic disease is characterized by infiltration of lipid-laden macrophages, multinucleated giant cells, an inflammatory infiltrate of lymphocytes and histiocytes in the bone marrow, and a generalized sclerosis of the long bones.

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (25.00)29.6817
2010's8 (66.67)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Cui, R1
Chen, M1
Dai, SM1
Ben-Yaakov, G1
Munteanu, D1
Sztarkier, I1
Fich, A1
Schwartz, D1
Gianfreda, D1
Nicastro, M1
Galetti, M1
Alberici, F1
Corradi, D1
Becchi, G1
Baldari, G1
De Filippo, M1
Ferretti, S1
Moroni, G1
Foti, R1
Di Gangi, M1
Jeannin, G1
Saffroy, R1
Emile, JF1
Buzio, C1
Vaglio, A1
Haroche, J1
Amoura, Z1
Vega, J1
Santamarina, M1
Furlanetto, TW1
Fischer, J1
Polanczyk, CA1
Vasconcelos, MV1
Jeon, IS1
Lee, SS1
Lee, MK1
Mahoozi, HR1
Zittermann, A1
Hakim Meibodi, K1
Burchert, W1
Gummert, JF1
Mirow, N1
Pan, A1
Doyle, T1
Schlup, M1
Lubcke, R1
Schultz, M1
Broccoli, A1
Stefoni, V1
Faccioli, L1
Agostinelli, C1
Spinardi, L1
Pastore Trossello, M1
Zinzani, PL1
Lopes Marques, CD1
Duarte, AL1
Cavalcanti Fd, Fde S1
Valentini, D1
Cappelli, C1
Mizzoni, F1
Noto, C1
Toscano, D1
Foco, M1
Trasimeni, G1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma: a Randomized Controlled Trial[NCT04448873]Phase 430 participants (Actual)Interventional2020-07-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for prednisone and Erdheim-Chester Disease

ArticleYear
Bilateral orbital Erdheim-Chester disease treated with 12 weekly administrations of VNCOP-B chemotherapy: a case report and a review of literature.
    Rheumatology international, 2012, Volume: 32, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Drug Administration Sch

2012

Trials

1 trial available for prednisone and Erdheim-Chester Disease

ArticleYear
Sirolimus plus prednisone for Erdheim-Chester disease: an open-label trial.
    Blood, 2015, Sep-03, Volume: 126, Issue:10

    Topics: Adult; Aged; Erdheim-Chester Disease; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; P

2015

Other Studies

10 other studies available for prednisone and Erdheim-Chester Disease

ArticleYear
Coated aorta in Erdheim-Chester disease.
    Rheumatology (Oxford, England), 2021, 02-01, Volume: 60, Issue:2

    Topics: Antirheumatic Agents; Aorta; Biopsy; Computed Tomography Angiography; Cyclophosphamide; Echocardiogr

2021
Erdheim Chester - a rare disease with unique endoscopic features.
    World journal of gastroenterology, 2014, Jul-07, Volume: 20, Issue:25

    Topics: Adult; Biomarkers; Biopsy; Colon; Colonoscopy; Diarrhea; Drug Therapy, Combination; Erdheim-Chester

2014
mTOR: a new target in Erdheim-Chester disease?
    Blood, 2015, Sep-03, Volume: 126, Issue:10

    Topics: Erdheim-Chester Disease; Female; Humans; Immunosuppressive Agents; Male; Prednisone; Sirolimus

2015
[Sirolimus and prednisone for the treatment of Erdheim-Chester disease with cardiac involvement: Report of one case].
    Revista medica de Chile, 2016, Volume: 144, Issue:3

    Topics: Aged; Anti-Inflammatory Agents; Cardiac Tamponade; Disease-Free Survival; Erdheim-Chester Disease; H

2016
A multiplication problem.
    The American journal of medicine, 2009, Volume: 122, Issue:1

    Topics: Aged; Aorta; Erdheim-Chester Disease; Humans; Immunosuppressive Agents; Interferon alpha-2; Interfer

2009
Chemotherapy and interferon-alpha treatment of Erdheim-Chester disease.
    Pediatric blood & cancer, 2010, Volume: 55, Issue:4

    Topics: Adolescent; Erdheim-Chester Disease; Female; Humans; Interferon-alpha; Methotrexate; Prednisone; Vin

2010
Erdheim-Chester disease in a female cardiac surgery patient.
    The Thoracic and cardiovascular surgeon, 2012, Volume: 60, Issue:6

    Topics: Aged; Biopsy; Cardiac Surgical Procedures; Erdheim-Chester Disease; Female; Heart Atria; Heart Disea

2012
Unusual manifestation of Erdheim-Chester disease.
    BMC gastroenterology, 2011, Jun-22, Volume: 11

    Topics: Aged; Diagnosis, Differential; Erdheim-Chester Disease; Gastrointestinal Diseases; Humans; Hydrocort

2011
Erdheim-Chester disease in Brazil.
    Annals of the rheumatic diseases, 2003, Volume: 62, Issue:3

    Topics: Erdheim-Chester Disease; Female; Glucocorticoids; Humans; Magnetic Resonance Imaging; Middle Aged; P

2003
[Erdheim-Chester disease: a non-Langerhans cell histiocytosis. A clinical-case and review of the literature].
    La Clinica terapeutica, 2004, Volume: 155, Issue:5

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antineoplastic Ag

2004